NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 446 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,373 | +3.6% | 604 | +6.3% | 0.00% | – |
| Q2 2023 | $4,220 | +10450.0% | 568 | -90.2% | 0.00% | – |
| Q1 2023 | $40 | +100.0% | 5,800 | +205.3% | 0.00% | – |
| Q4 2022 | $20 | -100.0% | 1,900 | -36.7% | 0.00% | -100.0% |
| Q3 2022 | $62,000 | +1450.0% | 3,000 | +3348.3% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 87 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -99.2% | 87 | -99.0% | 0.00% | -100.0% |
| Q4 2021 | $799,000 | -74.3% | 8,524 | -43.1% | 0.01% | -68.4% |
| Q3 2021 | $3,106,000 | -4.5% | 14,981 | -2.2% | 0.02% | -5.0% |
| Q2 2021 | $3,252,000 | +3.0% | 15,319 | -12.1% | 0.02% | 0.0% |
| Q1 2021 | $3,158,000 | +51.7% | 17,419 | -6.7% | 0.02% | +53.8% |
| Q4 2020 | $2,082,000 | +122.4% | 18,669 | +116.0% | 0.01% | +62.5% |
| Q3 2020 | $936,000 | +2363.2% | 8,642 | +1799.3% | 0.01% | – |
| Q2 2020 | $38,000 | +660.0% | 455 | +19.7% | 0.00% | – |
| Q1 2020 | $5,000 | – | 380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |